Sun Pharma's drug to treat alopecia areata gets USFDA nod

Sun Pharmaceutical Industries Ltd announced that the USFDA has approved its drug LEQSELVI (deuruxolitinib) for treating adults with severe alopecia areata. The approval is based on Phase 3 clinical trials involving 1,220 patients. LEQSELVI provides a new treatment option for patients with significant hair loss due to this autoimmune disorder.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/i9NwTQc
via IFTTT